Vakiener Victoria reported ARWR

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001826263-25-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 16, 2025

Published

Dec 18, 2025

Ingested by INSIDER

Nov 5, 04:26 UTC

Last re-read

Nov 5, 04:26 UTC

Extracted facts

Filer

Vakiener Victoria

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

ARROWHEAD PHARMACEUTICALS, INC.

Ticker

ARWR

Shares

7,819

Price per share

$0

Execution date (reported)

Dec 16, 2025

Owned after transaction

45.8K shares

Days from execution to publication

2

What this establishes

Vakiener Victoria filed this Form 4 reporting a grant or award of ARWR on Dec 16, 2025. It became public on Dec 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Vakiener Victoriacik:0001826263

Issuer

ARROWHEAD PHARMACEUTICALS, INC.cik:0000879407

Revision history · 0

No field has changed since this record was first ingested.